Perfil
Douglas E.
Feltner is a former VP & Global Head-Translational Medicine at Pfizer Inc., Vice President at Translational Medicine India, Inc., Chief Medical Officer at Embera NeuroTherapeutics, Inc., Vice President-Neuroscience Development at AbbVie, Inc., and Vice President-Clinical Development at Novartis Gene Therapies, Inc. He holds a doctorate degree from the University of Michigan Medical School.
Antiguos cargos conocidos de Douglas Feltner.
| Empresas | Cargo | Fin |
|---|---|---|
| EXICURE, INC. | Director Técnico/Científico/I+D | 31/01/2022 |
| PFIZER INC. | Corporate Officer/Principal | - |
| ABBVIE INC. | Corporate Officer/Principal | - |
| AVEXIS INC | Corporate Officer/Principal | - |
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinincal research solutions | Corporate Officer/Principal | - |
Formación de Douglas Feltner.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Translational Medicine India, Inc.
Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinincal research solutions | Commercial Services |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
University of Michigan Medical School
University of Michigan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure, Inc.
Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
- Bolsa de valores
- Insiders
- Douglas Feltner
















